Hepatic levels of bile acids in end-stage chronic cholestatic liver disease

Clinica Chimica Acta

Volumn 251, Issue 2, 1996, Pages 173-186

  Fischer, Sven ^a   Beuers, Ulrich ^a   Spengler, Ulrich ^a   Zwiebel, Franz M ^a   Koebe, Hans Günter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bile acids; Cholestasis; Gas chromatography; Liver; Liver, chorrhosis

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; LITHOCHOLIC ACID;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHOLESTASIS; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIVER; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

EID: 0030606673     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06305-X     Document Type: Article

References (30)

1. [1] Greim H, Trülzsch D, Czygan P, Rudick J, Hutterer F, Schaffner F, Popper H. Mechanism of cholestasis. 6. Bile acids in human liver with or without biliary obstruction. Gastroenterology 1972;63:837-845.
2. [2] Hofmann AF. Bile acid hepatotoxicity and the rationale of UDCA therapy in chronic cholestatic liver disease: some hypotheses. In: Paumgartner G, Stiehl A, Barbara L, Roda E, eds. Strategies for the Treatment of Hepatobiliary Diseases. Dordrecht: Kluwer Academic Publishers, 1990;13-33.
3. [3] Schölmerich J, Becker MS, Schmidt K, Schubert R, Kremer B, Feldhaus S, Gerok W. Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties: studies on isolated hepatocytes and lipid membrane vesicles. Hepatology 1984;4:661-666.
4. [4] Vyvoda OS, Coleman R, Holdsworth G. Effects of different bile salts upon the composition and morphology of a liver plasma membrane preparation. Biochim Biophys Acta 1977;465:68-76.
5. [5] Turjman N, Mendeloff AI, Jacob C, Guidry C, Nair PP. Isolation of tissue-bound lithocholic acid from livers of rats treated with methylazoxymethanol. J Steroid Biochem 1981;14:1237-1240.
6. [6] Turjman N, Nair PP. Nature of tissue-bound lithocholic acid and its implications in the role of bile acids in carcinogenesis. Cancer Res 1981;41:3761-3763.
7. [7] Setchell KDR, Matsui A. Serum bile acid analysis. Clin Chim Acta 1982;127:1-17.
8. 13C-labelled bile acids. J Lipid Res 1984;25:1313-1319.
9. [9] Parmentier G, Eyssen H. Synthesis of the specific monosulfates of cholic acid. Steroids 1975;26:721-729.
10. [10] Setchell KDR, Worthington J. A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse-phase octadecylsilane-bonded silica cartridges. Clin Chim Acta 1982;125:135-144.
11. [11] Andersen E, Karlaganis G, Sjövall J. Altered bile acid profiles in duodenal bile and urine in diabetic subjects. Eur J Clin Invest 1988;18:166-172.
12. [12] Miyazaki K, Nakayama F, Koga A. Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatozytes. Dig Dis Sci 1984;29(12):1123-1130.
13. [13] Vlahcevic ZR, Juttijdata P, Bell CC, Swell L. Bile acid metabolism in patients with cirrhosis. II. Cholic and chenodeoxycholic acid metabolism. Gastroenterology 1972;62:1174-1181.
14. [14] McCormick WC, Bell CC, Swell L, Vlahcevic R. Cholic acid synthesis as an index of the severity of liver disease in man. Gut 1973;14:895-902.
15. [15] Akashi Y, Miyazaki H, Yanagisawa J, Nakayama F. Bile acid metabolism in cirrhotic liver tissue-altered synthesis and impaired hepatic secretion. Clin Chim Acta 1987;168:199-206.
16. [16] Mehta SJ, Struthers JE, Kaye MD, Nayler JL. Biliary deoxycholate in patients with alcoholic cirrhosis. Gastroenterology 1974;67:674-679.
17. [17] Yoshida T, McCormick WC, Swell L, Vlahcevic ZR. Bile acid metabolism in cirrhosis. IV. Characterization of the abnormality in deoxycholic acid metabolism. Gastroenterology 1975;68:335-341.
18. [18] Binder HJ, Filburn B, Floch M. Bile acid inhibition of intestinal anaerobic organisms. Am J Clin Nutr 1975;28:119-125.
19. [19] Knodell RG, Kinsey MD, Boedeker EC, Collin DP. Deoxycholate metabolism in alcoholic cirrhosis. Gastroenterology 1976;71:196-201.
20. [20] Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fischer S, Paumgartner G. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology 1992;15:603-608.
21. [21] Iqbal S, Vickers C, Elias E. Sulphation and desulphation in normal human liver and primary biliary cirrhosis. Gut 1986;28:A1345.
22. [22] Hofmann AF. Bile acids. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathobiology. New York: Raven Press, 1988;553-572.
23. [23] Nair PP, Mendeloff AI, Vocci M, Bankoski J, Gorelik M, Herman G, Plapinger R. Lithocholic acid in human liver: identification of E-lithocholyl lysine in tissue protein. Lipids 1977;12:922-929.
24. [24] Yanagisawa J, Akashi J, Miyazaki H, Nakayama F. Critical evaluation of the existence of so-called tissue-bound lithocholate in human liver tissue by selected ion monitoring. J Lipid Res 1984;25:1263-1271.
25. [25] Nair PP, Kessie G, Flanagan VP. Reaffirmation of the validity of enzymatic cleavage of lithocholic acid from N-E-lithocholyl-L-lysine and N-ε-CBZ-N-E-lithocholyl-L-lysine. J Lipid Res 1986;27:905-909.
26. [26] Paumgartner G. Serum bile acids. J Hepatol 1986;2:291-298.
27. [27] Takikawa H, Beppu T, Seyama Y. Profiles of bile acids and their glucuronide and sulphate conjugates in the serum, urine and bile from patients undergoing bile drainage. Gut 1984;26:38-42.
28. [28] Javitt NB. Cholestasis in rats induced by taurolithocholate. Nature 1966;210:1262-1263.
29. [29] Priestly BG, Cote MG, Plaa GL. Biochemical and morphological parameters of taurolithocholate-induced cholestasis. Can J Physiol Pharmacol 1971;49:1078-1091.
30. [30] Miyai K, Price VM, Fisher MM. Bile acid metabolism in mammals. Ultrastructural studies on the intrahepatic cholestasis induced by lithocholic acid and chenodeoxycholic acid in the rat. Lab Invest 1971;24:292-302.